Literature DB >> 3015415

v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis.

K Brown, M Quintanilla, M Ramsden, I B Kerr, S Young, A Balmain.   

Abstract

Activated Harvey murine sarcoma virus ras genes were introduced into epidermal cells in vivo by direct application of retroviruses to mouse skin. Subsequent treatment with the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate (TPA) induced benign papillomas, some of which progressed to invasive carcinomas. Initiation with virus was irreversible for at least 4 months, since TPA treatment after this latency period produced papillomas within 4 weeks. Analysis of viral integration sites showed that carcinomas are clonal in origin. Both papillomas and carcinomas express virus-specific ras mRNA and the viral form of ras P21 protein. The results show that activated ras genes can replace chemical carcinogens in initiation of mouse skin carcinogenesis. This system presents a novel approach to in vivo analysis of the biological role of oncogenes in epithelial tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015415     DOI: 10.1016/0092-8674(86)90665-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  47 in total

1.  Retroviral transduction of the human c-Ha-ras-1 oncogene into midgestation mouse embryos promotes rapid epithelial hyperplasia.

Authors:  S J Compere; P A Baldacci; A H Sharpe; R Jaenisch
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

2.  The morphological and molecular features of the epithelial-to-mesenchymal transition.

Authors:  Gema Moreno-Bueno; Héctor Peinado; Patricia Molina; David Olmeda; Eva Cubillo; Vanesa Santos; José Palacios; Francisco Portillo; Amparo Cano
Journal:  Nat Protoc       Date:  2009-10-15       Impact factor: 13.491

3.  Targeted deletion and lipidomic analysis identify epithelial cell COX-2 as a major driver of chemically induced skin cancer.

Authors:  Jing Jiao; Tomo-O Ishikawa; Darren S Dumlao; Paul C Norris; Clara E Magyar; Carol Mikulec; Art Catapang; Edward A Dennis; Susan M Fischer; Harvey R Herschman
Journal:  Mol Cancer Res       Date:  2014-07-25       Impact factor: 5.852

4.  Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells.

Authors:  Bokai Zhu; Combiz Khozoie; Moses T Bility; Christina H Ferry; Nicholas Blazanin; Adam B Glick; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

5.  T-cell receptor gene rearrangement in primary tumors: effect of genetic background and inducing agent.

Authors:  L E Diamond; S R Sloan; A Pellicer; A C Hayday
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation?

Authors:  M Corominas; H Kamino; J Leon; A Pellicer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  Increased incidence of squamous cell carcinomas in Mastomys natalensis papillomavirus E6 transgenic mice during two-stage skin carcinogenesis.

Authors:  Iris Helfrich; Min Chen; Rainer Schmidt; Gerhard Fürstenberger; Annette Kopp-Schneider; David Trick; Hermann-Josef Gröne; Harald Zur Hausen; Frank Rösl
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors.

Authors:  M A Nelson; B W Futscher; T Kinsella; J Wymer; G T Bowden
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

9.  RasGRP1 transgenic mice develop cutaneous squamous cell carcinomas in response to skin wounding: potential role of granulocyte colony-stimulating factor.

Authors:  Federico R Diez; Ann A Garrido; Amrish Sharma; Courtney T Luke; James C Stone; Nancy A Dower; J Mark Cline; Patricia S Lorenzo
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

10.  The tumor promoter 12-O-tetradecanoylphorbol-13-acetate and the ras oncogene modulate expression and phosphorylation of gap junction proteins.

Authors:  J L Brissette; N M Kumar; N B Gilula; G P Dotto
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.